We have to look at patients holistically, who have kidney disease and diabetes, to address the totality of risks, certainly progression to kidney failure, but also prevention of cardiovascular events and deaths. Ozempic and other GLP-1s will be compared to another diabetes drug class, SGLT-2 inhibitors Given Ozempics reduction of kidney disease events in the FLOW study, it seems likely that the GLP-1s will be used together with and compared against SGLT-2 inhibitor drugs
Yes, Retatrutide has shown strong potential for weight loss in clinical trials
Comprehensive Safety and Effectiveness of Glutathione IV Therapy Can I Get At-Home Glutathione IV Treatments
The laser energy stimulates healing in your muscles and tissues and promotes better recovery and less pain
By influencing several pathways simultaneously, Retatrutide is being studied as a potential option for individuals who struggle with obesity and metabolic dysfunction
3.0% The Dysesthesia Signal Has Not Gone Away This is the one I asked about in June, and it's still here